These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15948360)

  • 21. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics for irritable bowel syndrome: should we give them full names?
    Álvarez-Sánchez Á; Rey E
    Rev Esp Enferm Dig; 2013 Jan; 105(1):1-2. PubMed ID: 23548003
    [No Abstract]   [Full Text] [Related]  

  • 23. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics in functional gastrointestinal disorders: what are the facts?
    Quigley EM
    Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome.
    van Zanten SV
    Gastroenterology; 2005 Aug; 129(2):772; author 772-3. PubMed ID: 16083745
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: probiotics and IBS - where are we now?
    Moran C; Shanahan F
    Aliment Pharmacol Ther; 2014 Aug; 40(3):318. PubMed ID: 25040745
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of the microbiota and intestinal mucosa in the pathophysiology and treatment of irritable bowel, irritable eye, and irritable mind syndrome].
    Fehér J; Kovács I; Pacella E; Radák Z
    Orv Hetil; 2014 Sep; 155(37):1454-60. PubMed ID: 25194867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OTC product: VSL #3: the living shield.
    Scolaro KL
    J Am Pharm Assoc (2003); 2008; 48(6):e156. PubMed ID: 19019794
    [No Abstract]   [Full Text] [Related]  

  • 30. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
    Brenner DM; Chey WD
    Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Irritable bowel syndrome. Reduction of symptoms, better quality of life].
    MMW Fortschr Med; 2011 May; 153(19):52-3. PubMed ID: 21612101
    [No Abstract]   [Full Text] [Related]  

  • 32. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R
    Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using metabolomics to decipher probiotic effects in patients with irritable bowel syndrome.
    Madsen K
    J Clin Gastroenterol; 2011; 45(5):389-90. PubMed ID: 21436725
    [No Abstract]   [Full Text] [Related]  

  • 35. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
    O'Mahony L; McCarthy J; Kelly P; Hurley G; Luo F; Chen K; O'Sullivan GC; Kiely B; Collins JK; Shanahan F; Quigley EM
    Gastroenterology; 2005 Mar; 128(3):541-51. PubMed ID: 15765388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
    J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
    Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical efficacy of activia tvorozhnaya in patients with the irritated bowels syndrome with the prevalence of constipations].
    Parfenov AI; Ruchkina IN; Silvestrova SIu
    Eksp Klin Gastroenterol; 2005; (3):37-42. PubMed ID: 16255551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.